Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells

Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells

Atherosclerosis and cardiovascular disease development is the outcome of intermediate processes where endothelial dysfunction and vascular inflammation are main protagonists. Cell-derived microvesicles (MVs), endothelial progenitor cells (EPCs), and circulating microRNAs (miRNAs) are known as biomar...

Full description

Bibliographic Details
Main Authors: Nicoleta Alexandru, Eugen Andrei, Florentina Safciuc, Emanuel Dragan, Ana Maria Balahura, Elisabeta Badila, Adriana Georgescu
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cells
Subjects:
cell-derived microvesicles (mvs)
endothelial progenitor cells (epcs)
micrornas
atherosclerosis
therapy
Online Access:https://www.mdpi.com/2073-4409/9/2/423

Similar Items

Similar Items